Tuesday, October 09, 2007

Health Canada pulls market approval for drug Prexige, citing liver problems

From the Canadian Press:
Health Canada has ordered the anti-inflammatory drug Prexige off the market, citing the potential for severe liver-related side-effects.

The department said it was stopping sales and would cancel market authorization for lumiracoxib, which is sold as Prexige by Novartis Pharmaceuticals Canada Inc.

People taking the drug are being instructed to talk with their doctors about finding an alternate pain relief therapy.

"Given the availability of alternative treatment not known to present a similar level of risk, Health Canada decided that the safest option was to withdraw the drug from the market," department spokesperson Alastair Sinclair said in e-mailed responses to questions. ...more

No comments: